Larvol Delta - Genetically-Engineered-Cells-COH06-With-or-Without-Atezolizumab-for-the-Treatment-of-Nonsmall-Cell-Lung-Cancer-Previously-Treated-With-PD1-andor-PDL1-Immune-Checkpoint-Inhibitors

COH06 - City of Hope

Tecentriq (atezolizumab) - Roche

cyclophosphamide - Generic mfg.

fludarabine IV - Generic mfg.

http://clinicaltrials.gov/ct2/show/NCT05334329

Apr 19, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next